Skip to content

Efficacy and Safety of Acupuncture Treatment as an Adjunctive Therapy After Knee Replacement

Efficacy and Safety of Acupuncture Treatment as an Adjunctive Therapy After Knee Replacement - Single-center, Pragmatic, Randomized, Assessor Blinded, Pilot Study-

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03633097
Enrollment
50
Registered
2018-08-16
Start date
2018-11-30
Completion date
2021-05-30
Last updated
2021-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupuncture, Knee Replacement

Brief summary

Efficacy and Safety of Acupuncture Treatment as an Adjunctive Therapy After Knee Replacement

Interventions

OTHERAcupuncture and Usual care

patients after surgery receive usual care(Cnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet) as well as acupuncture treatment as an adjunctive therapy

DRUGUsual care

patients after surgery receive usual care alone(Cnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet)

Sponsors

Korea Health Industry Development Institute
CollaboratorOTHER_GOV
Gachon University Gil Oriental Medical Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

single blinded, outcome assessor blinded

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject has a diagnosis of osteoarthritis and listed for an unilateral total knee replacement. * Subject has a normal cognitive function * Subject is willing and able to give informed consent for participation in the study.

Exclusion criteria

* Those who have undergone total knee arthroplasty due to gout * Those who have had total knee arthroplasty due to trauma * Those who have had total knee arthroplasty due to autoimmune related diseases such as rheumatoid arthritis * Those who are participating in other clinical trials * Those who have a history of participating in other clinical trials within one month * Those who are difficult to write a research consent form * Those who are judged to be inappropriate for the clinical study by the researchers.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in Korean version of Western Ontario and McMaster Universities Arthritis IndexScreening, day 11, day 21K-WOMAC is widely used in the evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items divided into 3 subscales

Secondary

MeasureTime frameDescription
Change from baseline in Physical Condition related with mobility at every visitScreening, day 11, day 84mobility (5 meters walking test at comfortable speed - 5mWT) (meters/second)
Change from baseline in Physical Condition related with endurance at every visitScreening, day 11, day 84endurance (Sit-to-stand test - STS) (seconds)
Change from baseline in Numeric rating scaleScreening, baseline, day 5, 11, 21, 28, 84NRS range was 0-10 with 0 being no pain and 10 the worst pain possible.
Change from baseline in Alternative-Step Test at every visitScreening, day 11, day 84a functional test measuring clinical balance performance, and it has been shown to predict fall risk among elderly subjects (seconds)
Change from baseline in Range of motionScreening, baseline, day 5, 11, 28, 84Compare flexion and extension angle using long arm goniometer between experimental and comparator group
Change from baseline in Timed Up and Go Test at every visitScreening, day 11, day 84a functional test evaluating the time to rise from a chair, walk 3 meters, turn around, walk back to the chair and sit down (abnormal cut-off value \>12 seconds).

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026